Adapthealth Corp (AHCO)

$9.76

-0.84

(-7.92%)▲

Market is closed - opens 7 PM, 08 May 2024

Performance

  • $9.17
    $10.11
    $9.76
    downward going graph

    6.05%

    Downside

    Day's Volatility :9.3%

    Upside

    3.46%

    downward going graph
  • $6.37
    $15.37
    $9.76
    downward going graph

    34.73%

    Downside

    52 Weeks Volatility :58.56%

    Upside

    36.5%

    downward going graph

Returns

PeriodAdapthealth Corp
3 Months
37.27%
6 Months
50.15%
1 Year
-19.14%
3 Years
-60.85%

Highlights

Market Capitalization
1.3B
Book Value
$11.33
Earnings Per Share (EPS)
-5.31
Wall Street Target Price
11.85
Profit Margin
-21.21%
Operating Margin TTM
12.15%
Return On Assets TTM
3.35%
Return On Equity TTM
-37.24%
Revenue TTM
3.2B
Revenue Per Share TTM
23.85
Quarterly Revenue Growth YOY
10.0%
Gross Profit TTM
490.8M
EBITDA
643.1M
Diluted Eps TTM
-5.31
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.8
EPS Estimate Next Year
1.03
EPS Estimate Current Quarter
0.18
EPS Estimate Next Quarter
0.06

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Adapthealth Corp(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
4
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 21.41%

Current $9.76
Target $11.85

Company Financials

FY18Y/Y Change
Revenue
345.3M
↑ 79.31%
Net Income
2.1M
↓ 302432.46%
Net Profit Margin
0.6%
↑ 0.6%
FY19Y/Y Change
Revenue
529.6M
↑ 53.4%
Net Income
12.2M
↑ 486.6%
Net Profit Margin
2.31%
↑ 1.71%
FY20Y/Y Change
Revenue
1.1B
↑ 99.45%
Net Income
-58.7M
↓ 579.84%
Net Profit Margin
-5.56%
↓ 7.87%
FY21Y/Y Change
Revenue
2.5B
↑ 132.35%
Net Income
156.2M
↓ 365.97%
Net Profit Margin
6.36%
↑ 11.92%
FY22Y/Y Change
Revenue
3.0B
↑ 21.02%
Net Income
69.3M
↓ 55.62%
Net Profit Margin
2.33%
↓ 4.03%
FY23Y/Y Change
Revenue
3.2B
↑ 7.73%
Net Income
-678.9M
↓ 1079.42%
Net Profit Margin
-21.21%
↓ 23.54%
Q3 FY22Q/Q Change
Revenue
557.7M
↓ 23.36%
Net Income
13.4M
↑ 4.33%
Net Profit Margin
2.4%
↑ 0.63%
Q4 FY22Q/Q Change
Revenue
780.3M
↑ 39.92%
Net Income
-1.6M
↓ 111.72%
Net Profit Margin
-0.2%
↓ 2.6%
Q1 FY23Q/Q Change
Revenue
744.6M
↓ 4.57%
Net Income
15.7M
↓ 1099.81%
Net Profit Margin
2.11%
↑ 2.31%
Q2 FY23Q/Q Change
Revenue
793.3M
↑ 6.53%
Net Income
14.0M
↓ 11.01%
Net Profit Margin
1.76%
↓ 0.35%
Q3 FY23Q/Q Change
Revenue
804.0M
↑ 1.35%
Net Income
-454.1M
↓ 3348.74%
Net Profit Margin
-56.47%
↓ 58.23%
Q4 FY23Q/Q Change
Revenue
858.2M
↑ 6.74%
Net Income
-254.5M
↓ 43.95%
Net Profit Margin
-29.65%
↑ 26.82%
FY18Y/Y Change
Total Assets
254.1M
↑ 81713.0%
Total Liabilities
8.6M
↑ 2894.8%
FY19Y/Y Change
Total Assets
227.8M
↓ 10.34%
Total Liabilities
212.7M
↑ 2380.62%
FY20Y/Y Change
Total Assets
1.8B
↑ 701.57%
Total Liabilities
1.4B
↑ 573.03%
FY21Y/Y Change
Total Assets
5.3B
↑ 187.5%
Total Liabilities
3.2B
↑ 122.41%
FY22Y/Y Change
Total Assets
5.2B
↓ 0.59%
Total Liabilities
3.1B
↓ 3.83%
FY23Y/Y Change
Total Assets
4.6B
↓ 11.49%
Total Liabilities
3.2B
↑ 2.98%
Q3 FY22Q/Q Change
Total Assets
5.2B
↑ 0.69%
Total Liabilities
3.1B
↑ 0.45%
Q4 FY22Q/Q Change
Total Assets
5.2B
↓ 0.35%
Total Liabilities
3.1B
↓ 0.53%
Q1 FY23Q/Q Change
Total Assets
5.3B
↑ 1.22%
Total Liabilities
3.1B
↑ 1.77%
Q2 FY23Q/Q Change
Total Assets
5.2B
↓ 1.52%
Total Liabilities
3.0B
↓ 3.21%
Q3 FY23Q/Q Change
Total Assets
4.7B
↓ 9.18%
Total Liabilities
3.0B
↓ 1.01%
Q4 FY23Q/Q Change
Total Assets
4.6B
↓ 2.23%
Total Liabilities
3.2B
↑ 5.62%
FY18Y/Y Change
Operating Cash Flow
68.4M
↑ 48.98%
Investing Cash Flow
-96.3M
↑ 538.6%
Financing Cash Flow
251.3M
↑ 209657.17%
FY19Y/Y Change
Operating Cash Flow
60.4M
↓ 11.7%
Investing Cash Flow
-84.9M
↓ 11.85%
Financing Cash Flow
-13.9M
↓ 105.53%
FY20Y/Y Change
Operating Cash Flow
195.6M
↑ 223.8%
Investing Cash Flow
-815.7M
↑ 861.12%
Financing Cash Flow
643.2M
↓ 4729.33%
FY21Y/Y Change
Operating Cash Flow
275.7M
↑ 40.92%
Investing Cash Flow
-1.8B
↑ 123.7%
Financing Cash Flow
1.6B
↑ 148.58%
FY22Y/Y Change
Operating Cash Flow
373.9M
↑ 35.62%
Investing Cash Flow
-411.2M
↓ 77.47%
Financing Cash Flow
-66.1M
↓ 104.13%
Q3 FY22Q/Q Change
Operating Cash Flow
107.0M
↑ 3.43%
Investing Cash Flow
-95.3M
↑ 6.02%
Financing Cash Flow
-19.7M
↑ 39.48%
Q4 FY22Q/Q Change
Operating Cash Flow
96.9M
↓ 9.44%
Investing Cash Flow
-145.8M
↑ 52.91%
Financing Cash Flow
-15.6M
↓ 21.05%
Q1 FY23Q/Q Change
Operating Cash Flow
140.2M
↑ 44.7%
Investing Cash Flow
-89.6M
↓ 38.57%
Financing Cash Flow
4.4M
↓ 128.53%
Q2 FY23Q/Q Change
Operating Cash Flow
86.3M
↓ 38.45%
Investing Cash Flow
-100.2M
↑ 11.87%
Financing Cash Flow
-42.4M
↓ 1053.19%

Technicals Summary

Sell

Neutral

Buy

Adapthealth Corp is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • OEP CAPITAL ADVISORS, L.P.

    10.13%

  • Deerfield Management Co

    9.98%

  • BlackRock Inc

    9.64%

  • FMR Inc

    6.48%

  • Vanguard Group Inc

    6.35%

  • Reinhart Mahoney Capital Management Inc

    2.98%

Company Information

at adapthealth, we believe everyone deserves a comfortable and independent life with access to products and services tailored to empower patients to live their best lives -- out of the hospital and in their homes. we are a full-service home medical equipment and respiratory company with operations in 46 states offering a breadth of clinically-focused products and services to help patients with daily activities of life including: sleep and respiratory therapy, mobility products, wound care, non-invasive ventilation and nutrition.

Organization
Adapthealth Corp
Employees
10700
CEO
Mr. Richard Alan Barasch
Industry
Finance

Discover More

FAQs